Antibody responses to Fusobacterium nucleatum Proteins in prediagnostic blood samples are not associated with risk of developing colorectal cancer
Files
Publication date
2019
Authors
Butt, J.
Jenab, M.
Pawlita, M.
Overvad, K.
Tjonneland, A.
Olsen, A.
Boutron-Ruault, M.-C.
Carbonnel, F.
Mancini, F.R.
Kaaks, R.
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, SDG 3 - Good Health and Well-being
Citation
Butt, J, Jenab, M, Pawlita, M, Overvad, K, Tjonneland, A, Olsen, A, Boutron-Ruault, M-C, Carbonnel, F, Mancini, F R, Kaaks, R, Kuhn, T, Boeing, H, Trichopoulou, A, Karakatsani, A, Palli, D, Pala, V M, Tumino, R, Sacerdote, C, Panico, S, Bueno-De-Mesquita, B, Van Gils, C H, Vermeulen, R C H, Weiderpass, E, Quiros, J R, Duell, E J, Sanchez, M-J, Dorronsoro, M, Huerta, J M, Ardanaz, E, Van Guelpen, B, Harlid, S, Perez-Cornago, A, Gunter, M J, Murphy, N, Freisling, H, Aune, D, Waterboer, T & Hughes, D J 2019, 'Antibody responses to Fusobacterium nucleatum Proteins in prediagnostic blood samples are not associated with risk of developing colorectal cancer', Cancer Epidemiology Biomarkers and Prevention, vol. 28, no. 9, pp. 1552-1555. https://doi.org/10.1158/1055-9965.EPI-19-0313